美国儿童心室辅助装置感染的并发症:Pedimacs登记数据
该研究基于Pedimacs登记(2012年9月19日至2015年12月31日)的耐久性VAD数据,分析222例患儿248次植入的感染情况。感染占报告不良事件的17%(96/564),以非装置感染最常见(51%),其次为脓毒症(24%)、外部泵组件感染(20%)和内部泵组件感染(5%)。感染后生存率降低仅见于连续流(CF)患者(p=0.008)。
要点
- 感染是儿童VAD植入后最常见的不良事件,占17%。
- 非装置感染最常见(51%),细菌性感染占73%。
- 既往感染史是未来感染的最佳预测因素。
核心结论
- 感染是儿童VAD植入后最常见的不良事件,非装置感染最常见。
- 未来感染的最佳预测因素是既往感染史。
- 连续流患者感染后死亡风险更高(p=0.008)。
研究设计与样本
- 回顾性分析Pedimacs登记(2012年9月19日至2015年12月31日)的耐久性VAD数据。
- 共222例患者、248次植入,平均年龄11±6.4岁,中位随访2.4患者月(<1天至2.6年)。
主要发现
- 感染占报告不良事件的17%(96/564)。
- 感染类型:非装置感染51%,脓毒症24%,外部泵组件感染20%,内部泵组件感染5%。
- 大多数感染为细菌性(73%),仅需静脉治疗(77%)。
- 脉冲流患者较连续流患者更年轻(4±4 vs 14±4岁;p<0.0001),更可能有先天性心脏病(25% vs 12%;p=0.03)、既往手术(53% vs 26%;p<0.0001)和既往ECMO(24% vs 7%;p=0.0003)。
- 感染后生存率降低仅见于连续流患者(p=0.008)。
关键数值与推荐
- 感染风险在稳定期,有既往感染史和有非感染性重大不良事件史的患者中更高。
临床怎么用
- 儿童VAD患者应警惕感染,尤其是有既往感染史者。
- 连续流患者感染后需加强监测和干预以降低死亡风险。
局限性
- 数据来自登记研究,可能存在报告偏倚。
- 随访时间中位仅2.4患者月,长期感染风险未充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infections are frequent in pediatric ventricular assist device (VAD) patients. In this study we aimed to describe infections in durable VAD patients reported to Pedimacs. METHODS: Durable VAD data from the Pedimacs registry (September 19, 2012 to December 31, 2015) were analyzed. Infections were described with standard descriptive statistics, Kaplan-Meier analysis and competing outcomes analysis. RESULTS: There were 248 implants in 222 patients, with a mean age and a median follow-up of 11 ± 6.4 years and 2.4 patient-months (<1 day to 2.6 years), respectively. Device types were pulsatile flow (PF) in 91 (41%) patients and continuous flow (CF) in 131 (59%) patients. PF patients were younger (4 ± 4 vs 14 ± 4 years; p < 0.0001) and were more likely to have congenital heart disease (25% vs 12%; p = 0.03), prior surgery (53% vs 26%; p < 0.0001) and prior extracorporeal membrane oxygenation (24% vs 7%; p = 0.0003). Infection accounted for 17% (96 of 564) of the reported adverse events (AEs). A non-device infection was most common (51%), followed by sepsis (24%), external pump component infection (20%) and internal pump component infection (5%). Most infections were bacterial (73%) and required intravenous therapy only (77%). The risk of infection in the constant phase was higher in patients with a history of prior infection and in patients with a history of a non-infectious major AEs. Survival was lower after infection only in CF patients (p = 0.008). CONCLUSIONS: Infection was the most common AE after pediatric VAD implantation. Non-device infections were most common. The best predictor of a future infection was a past infection. CF patients have higher risk of death after an infection.
引用
- Auerbach SR, Richmond ME, Schumacher KR, et al. Infectious complications of ventricular assist device use in children in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs). J Heart Lung Transplant. 2017. PMID: 29107545. doi:10.1016/j.healun.2017.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。